Business at a Glance
* SCRIP Rankings 2016 ** Excludes Japan *** Includes countries like Brazil, Russia, India, China and South Africa **** In terms of retail formulation sales (Source: IMS)
Our Business is Primarily Structured into Drug Discovery & Development, Branded and Generic Formulations, and Active Pharmaceutical Ingredients (APIs). Our fast growing formulations business services the requirements of developed markets such as the United States and Europe. We have also built a strong presence in the branded generic formulations segment across emerging economies like India, Russia and Brazil. With a presence across the value chain, we market APIs to regulated and semi-regulated markets. Our Drug Discovery has 2 New Chemical Entities (NCEs) and 5 New Biological Entities (NBEs) which are in various stages of pre-clinical and clinical development. It is this global footprint that helps us in our mission of enriching lives worldwide.
We believe innovation is the only way to build a truly global organization that delivers outstanding results. In line with this belief, our ground-breaking drug discovery efforts are focused on the therapeutic areas of inflammation, pain and oncology.
Our Generic Formulations business primarily comprises of the U.S and Western Europe. Our U.S business is the largest market for us with more than 100 products authorized to distribute and approximately 60 pending approvals with the U.S. FDA. We also have a strong presence in the UK and are the fastest growing generics company in Germany.
In pursuit of the mission of enriching lives, our Branded Formulations business has grown from strength-to-strength in the emerging markets globally, focused on the therapeutic areas of dermatology, anti-infective, respiratory, cardiology, diabetes, gynecology, oncology and the central nervous system.
Active Pharmaceutical Ingredients
Our API division partners with leading global generic companies, supporting through advanced process chemistry skills and innovative intellectual property. We are a market leader for many API products in semiregulated markets and regulated markets.